Trupanion (NASDAQ:TRUP) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Wednesday.
According to Zacks, “Trupanion, Inc. operates as a direct-to-consumer monthly subscription service provider of a medical insurance plan for cats and dogs. It operates primarily in Canada, Puerto Rico, and the United States. The Company serves pet owners and veterinarians. Trupanion, Inc. is headquartered in Seattle, Washington. “
Other equities research analysts also recently issued reports about the company. Lake Street Capital lifted their price objective on Trupanion from $32.00 to $41.00 and gave the stock a “buy” rating in a report on Wednesday, February 14th. Stifel Nicolaus restated a “buy” rating and set a $34.00 price objective (up from $33.00) on shares of Trupanion in a report on Wednesday, February 14th. Northland Securities restated a “buy” rating and set a $38.00 price objective on shares of Trupanion in a report on Thursday, February 8th. BidaskClub upgraded Trupanion from a “hold” rating to a “buy” rating in a report on Monday, December 18th. Finally, ValuEngine downgraded Trupanion from a “buy” rating to a “hold” rating in a report on Wednesday, March 7th. Four equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $35.57.
Trupanion (NASDAQ:TRUP) last posted its quarterly earnings data on Tuesday, February 13th. The financial services provider reported ($0.05) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by ($0.03). Trupanion had a negative return on equity of 6.66% and a negative net margin of 0.62%. The business had revenue of $66.55 million for the quarter, compared to analysts’ expectations of $65.60 million. sell-side analysts anticipate that Trupanion will post -0.05 earnings per share for the current year.
In other news, Director Murray B. Low sold 3,000 shares of the business’s stock in a transaction that occurred on Thursday, February 22nd. The stock was sold at an average price of $28.42, for a total value of $85,260.00. Following the completion of the sale, the director now directly owns 194,281 shares in the company, valued at approximately $5,521,466.02. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Darryl Rawlings sold 3,500 shares of the business’s stock in a transaction that occurred on Tuesday, January 16th. The shares were sold at an average price of $34.08, for a total value of $119,280.00. Following the completion of the sale, the insider now owns 1,386,476 shares of the company’s stock, valued at $47,251,102.08. The disclosure for this sale can be found here. Insiders sold a total of 20,500 shares of company stock valued at $641,410 over the last quarter. Company insiders own 31.24% of the company’s stock.
Hedge funds and other institutional investors have recently modified their holdings of the company. First Mercantile Trust Co. bought a new stake in shares of Trupanion in the 4th quarter valued at approximately $129,000. JPMorgan Chase & Co. bought a new stake in shares of Trupanion in the 3rd quarter valued at approximately $143,000. Advisor Group Inc. bought a new stake in shares of Trupanion in the 4th quarter valued at approximately $182,000. Oppenheimer Asset Management Inc. bought a new stake in shares of Trupanion in the 3rd quarter valued at approximately $221,000. Finally, Voya Investment Management LLC bought a new stake in shares of Trupanion in the 2nd quarter valued at approximately $215,000. Institutional investors and hedge funds own 74.75% of the company’s stock.
TRADEMARK VIOLATION WARNING: This piece of content was originally posted by American Banking News and is owned by of American Banking News. If you are reading this piece of content on another website, it was copied illegally and republished in violation of international copyright and trademark legislation. The original version of this piece of content can be accessed at https://www.americanbankingnews.com/2018/03/14/trupanion-trup-upgraded-to-hold-by-zacks-investment-research.html.
Trupanion Company Profile
Trupanion, Inc provides medical insurance plans for cats and dogs throughout the United States, Canada and Puerto Rico. The Company operates in two business segments: subscription business and other business. The subscription business segment includes monthly subscriptions for its medical plan, which are marketed to consumers.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.